Aug 2026· European Journal of Radiology· Vol 205, pp.
113190
· 0 citations· 32 references
Medicine
TL;DR
WEPCAST derived PS is higher in remission phase NMOSD than in RRMS and HCs, suggesting altered BBB water exchange during clinical remission, and these exploratory group level findings warrant validation in larger longitudinal cohorts.
Abstract
Objective
Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory demyelinating disease leading to astrocytic and neurovascular unit injury. Although BBB structural disruption during acute attacks is well established, BBB water exchange during clinical remission remains unclear. This study aimed to quantify BBB water exchange in remission phase NMOSD using water-extraction-with-phase-contrast arterial spin labeling (WEPCAST) MRI and compare these findings with those in relapsing remitting multiple sclerosis (RRMS) and healthy controls (HCs).
Methods
Twenty-seven patients with NMOSD (42.5 ± 11.2 years, 27 females), 18 patients with RRMS (36.9 ± 11.9 years, 16 females), and 22 age- and sex-matched HCs (43.1 ± 9.5 years, 22 females) were prospectively enrolled. Remission was defined as no clinical relapse or new MRI lesion within 3 months before imaging. Brain MRI included FLAIR, phase contrast, T1 weighted, and WEPCAST sequences. BBB water exchange was quantified using the WEPCAST derived permeability-surface area product (PS), and quantitative white matter hyperintensity (WMH) volume was assessed on FLAIR images. Pairwise linear regression analyses were used for group comparison with covariate adjustment.
Results
NMOSD patients in remission demonstrated significantly higher PS values (141.5 ± 33.7 ml/100 g/min) than RRMS patients (117.8 ± 20.8 mL/100 g/min; p < 0.05) and HCs (120.3 ± 16.8 mL/100 g/min; p < 0.05), whereas RRMS did not differ from HCs. In pairwise regression analyses, PS remained significantly higher in NMOSD than in RRMS and HCs after covariate adjustment and after additional adjustment for WMH volume.
Conclusion
WEPCAST derived PS is higher in remission phase NMOSD than in RRMS and HCs, suggesting altered BBB water exchange during clinical remission. These exploratory group level findings warrant validation in larger longitudinal cohorts.
Therapeutic Plasma Exchange is a safe and effective rescue therapy for steroid-refractory NMOSD exacerbations, producing substantial neurological and visual recovery with a favorable safety profile.
Alka Kumari, Sarita Sharma, Ajay Kumar et al.· Therapeutic apheresis and di...· 0 citations
Background and Objectives Myelitis is a common manifestation of aquaporin-4 immunoglobulin G–seropositive (AQP4-IgG+) neuromyelitis optica spectrum disorder (NMOSD), with longitudinally extensive transverse myelitis (LETM) as a characteristic MRI feature. Bright spotty lesions (BSLs) and a novel “double-contoured LETM”...
Nontapat Sukhonpanich, C. Ngamsombat, Sittaya Buathong et al.· Neurology· 0 citations
Background Guillain–Barré syndrome (GBS) is an acute immune-mediated disease of the peripheral nervous system, with accumulating evidence of increased levels of multiple inflammatory factors in the central nervous system. Previous studies have suggested that inflammatory factors may mediate changes in brain structure a...
Wei Wang, Xin Wang, Si-Yu Fan et al.· Frontiers in Immunology· 0 citations
Importance
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating disease distinct from multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD). Magnetic resonance imaging (MRI) is central to confirming attacks, defining lesion di...
E. Flanagan, Brenda L. Banwell, Laura Cacciaguerra et al.· JAMA Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.